ICU Medical, Incorporated  

(Public, NASDAQ:ICUI)   Watch this stock  
Find more results for ICUI
215.30
+0.30 (0.14%)
Real-time:   9:59AM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 214.27 - 216.15
52 week 127.00 - 216.55
Open 215.00
Vol / Avg. 4,393.00/121,376.00
Mkt cap 4.33B
P/E 140.61
Div/yield     -
EPS 1.53
Shares 21.05M
Beta 0.33
Inst. own 77%
Nov 9, 2017
Q3 2017 ICU Medical Inc Earnings Call - Webcast
Nov 9, 2017
Q3 2017 ICU Medical Inc Earnings Release
Sep 11, 2017
ICU Medical Inc at Morgan Stanley Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin 0.04% 16.63%
Operating margin 1.41% 22.25%
EBITD margin - 31.13%
Return on average assets 0.04% 9.48%
Return on average equity 0.05% 10.17%
Employees 7,000 -
CDP Score - -

Address

951 Calle Amanecer
SAN CLEMENTE, CA 92673
United States - Map
+1-949-3662183 (Phone)
+1-949-3668368 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ICU Medical, Inc. is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company's product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems. The primary critical care products it manufactures are Hemodynamic Monitoring Systems, SafeSet Closed Blood Sampling and Conservation System, Transpac Consumable Blood Pressure Transducers and Other Critical Care Products. The primary oncology products it manufactures are ChemoLock Needlefree CSTD, ChemoClave Needlefree CSTD and Diana Hazardous Drug Compounding System. As of December 31, 2016, its products were used in acute care hospitals and ambulatory clinics in more than 65 countries throughout the world.

Officers and directors

Vivek Jain Chairman of the Board, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Scott E. Lamb Chief Financial Officer, Treasurer
Age: 54
Bio & Compensation  - Reuters
Alison D. Burcar Corporate Vice President, General Manager - Infusion Consumables
Age: 44
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tom McCall Corporate Vice President - Marketing and Communications, General Manager - Critical Care
Age: 59
Bio & Compensation  - Reuters
Steven C. Riggs Corporate Vice President - Operations
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Elisha W. Finney Independent Director
Age: 55
Bio & Compensation  - Reuters
Douglas E. Giordano Independent Director
Age: 53
Bio & Compensation  - Reuters
David C. Greenberg Independent Director
Age: 50
Bio & Compensation  - Reuters
Joseph R. Saucedo Independent Director
Age: 74
Bio & Compensation  - Reuters
Robert S. Swinney M.D. Independent Director
Age: 71
Bio & Compensation  - Reuters